Pinned
🙂 Very pleased to share our manuscript, just published in @BCD_AACR ➡️ Integrated analysis of genomics, PCR responses and outcomes of CBF-AML with FLAG based Rx on a phase 2 trial 🩸🧬 @UTMDAnderson @GBorthakur
Jayastu Senapati
1,877 posts
Jayastu Senapati
@jayastuMD
Assistant Professor, Dept. of Leukemia,
MD Anderson Cancer Center Houston, Texas
Patients First. EndLeukemia! 🧬 TP53
🇮🇳🌍🇺🇸
- 🙏🏼 I am happy to share that I have joined as Asst Prof in the Dept of Leukemia at MD Anderson Cancer Center, Houston. Years of education, training & blessings from well wishers have culminated into a surreal moment of joy. Hope to strive for the best for our patients & science 🙏🏼
- DM in Clinical Haematology (AIIMS ND) it is! Thanks to my wife, family, and friends for supporting me throughout and my mentors for believing in me. Moving on to Leukemia fellowship at MDACC Houston @MDAndersonNews
- What an incredible fellow's graduation night with our esteemed faculty and mentors 🥂! I am blessed & grateful to be a part of this wonderful dept for the last yr. Humbled to receive the Research fellow of the year award 🙏🏼. @DrHKantarjian @TapKadia @garciamanero @MDAndersonNews
- Words fail to express my sincere gratitude to the amazing Dept of Leukemia @MDAndersonNews & @DrHKantarjian for giving me this opportunity. I have met some of the nicest & most inspiring people here. 🙏🏼 to God, my parents & family, & my wife @AnweshaRayS for supporting me always.Super cheers to our super 🌟 Leukemia fellow Dr Senapati @jayastuMD who is completing Leukemia fellowship and will join us as Faculty in the Department of Leukemia 👏👏🎊🎉@MDAndersonNews Wishing you all the BEST!! WELCOME!! Super proud @DrHKantarjian @garciamanero @TapKadia
- ➡️ Check out our latest paper 📃 just out in @BloodJournal analyzing the outcomes of patients with Newly Dx AML having Splicing Factor gene mutations 🧬and the impact of Venetoclax based regimens 💊 @ CDDiNardo @DrHKantarjian @garciamanero @sanamloghavi @MDAndersonNews #leusm
@MDAndersonNews #Leukemia researchers identify the use of venetoclax helps to eliminate the adverse prognostic impact of splicing factor mutations in pts with newly diagnosed #AML | @BloodJournal doi.org/10.1182/blood.… #leusm - Very happy to have reviewed with Prof @Kadia how to choose the right FLT3 inhibitor in patients with AML. When options increase the right choice can get tougher! link.springer.com/article/10.100… @SpringerNature
- ➡️ Check out our latest paper reviewing the treatment of CML in 2023 in @BloodCancerJnl: we discuss the latest concepts in the field focussing on the ideal option for the patient👨🏻⚕️ Honored to have authored this paper under Prof @DrHKantarjian's mentorship. @MDAndersonNews #leusm
Discussing treatment choices and endpoints in #CML: what is best for the patient in 2023? Please check out our review just published in @BloodCancerJnl. @jayastuMD of @MDAndersonNews #Leukemia nature.com/articles/s4140… #leusm - Grateful to be a part of the Leuk Dept @MDAndersonNews @DrHKantarjian 🙏🏼 ✅All 6 abstracts accptd for #EHA2022. Thankful to my mentors @GBorthakur,@NitinJainMD @NicholasShortMD,@bose_prithviraj & Dr.DiNardo for this opportunity. Elated for the @EHA_Hematology travel award #leusm
- A profoundly treasured moment at #ASH22. Proud feeling for any @OffCMCVellore alumnus to share the frame with a legend of the field Prof @VincentRK, who knowingly and unknowingly has inspired many across the 🌎 and 🇮🇳 to take up hematology as a career and passion.
- Finishing the wonderful and invigorating month-long inpatient rotation with the awesome @Daver_Leukemia. Learnt a lot of leukemia and even beyond! #leusm @MDAndersonNews
- ✅ A small effort highlighting the challenges in the care of pts with AML in LMICs @TheLancetHaem: many efforts are being led by Govt & Pvt groups in India to reduce the gaps in AML care. The benefits of leuk research & improving outcomes should become a more global phenomenon 🌏
A viewpoint in @TheLancetHaem to understand the hurdles of AML care in India and LMICs. This article summarises these challenges and offers a few redressals. @jayastuMD @akhilrk1989 @TribikramHemat @ Mukul Aggarwal AIIMS thelancet.com/journals/lanha… - 👨🏻⚕️Looking forward to share our long term follow up data of CRLF2 rearranged Ph-like ALL @ASCO 2022, under the mentorship of @NitinJainMD. Humbled to have received the ASCO Conquer Cancer Merit Award @ConquerCancerFd 2022 🇺🇲🌍🇮🇳
- Missing #ASH23 but Ending Leukemia! 👨🏻⚕️ December Leukemia inpatient service at @MDAndersonNews. The opportunity to help our patients, makes everyday a blessing! ☀️
